Peck Bill 4
4 · Twist Bioscience Corp · Filed Sep 5, 2019
Insider Transaction Report
Form 4
Peck Bill
Chief Technology Officer
Transactions
- Sale
Common Stock
2019-09-03$27.87/sh−11,493$320,302→ 711,839 total - Sale
Common Stock
2019-09-03$28.88/sh−6,500$187,741→ 705,339 total - Sale
Common Stock
2019-09-03$29.82/sh−2,454$73,167→ 702,885 total
Footnotes (5)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- [F2]Represents the aggregate of sales effected on the same day at different prices.
- [F3]Represents the weighted average sales price per share. The shares sold at prices ranging from $27.41 to $28.375 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F4]Represents the weighted average sales price per share. The shares sold at prices ranging from $28.47 to $29.45 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F5]Represents the weighted average sales price per share. The shares sold at prices ranging from $29.48 to $30.14 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.